A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE

被引：121
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohnohigashi, Osaka 5898511, Japan
来源：
LIVER CANCER | 2019年 / 8卷 / 05期
关键词：
CLINICAL-PRACTICE GUIDELINES; TRANSARTERIAL CHEMOEMBOLIZATION; GROWTH-FACTOR; SORAFENIB; CANCER; SUBCLASSIFICATION; CRITERIA; PROPOSAL; REFRACTORINESS; HETEROGENEITY;
D O I：
10.1159/000502905
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：299 / 311
页数：13
相关论文
共 46 条
  • [1] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
    Abou-Alfa, G. K.
    Meyer, T.
    Cheng, A. -L.
    El-Khoueiry, A. B.
    Rimassa, L.
    Ryoo, B. -Y.
    Cicin, I.
    Merle, P.
    Chen, Y. H.
    Park, J. -W.
    Blanc, J. -F.
    Bolondi, L.
    Klumpen, H. -J.
    Chan, S. L.
    Zagonel, V.
    Pressiani, T.
    Ryu, M. -H.
    Venook, A. P.
    Hessel, C.
    Borgman-Hagey, A. E.
    Schwab, G.
    Kelley, R. K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 54 - 63
  • [2] [Anonymous], 2018, J FORMOS MED ASSOC, DOI [DOI 10.1016/J.JFMA.2017.09.007, 10.1016/j.jfma.2017.09.007]
  • [3] Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2
    Arizumi, Tadaaki
    Minami, Tomohiro
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Ida, Hiroshi
    Ueshima, Kazuomi
    Kamata, Ken
    Minaga, Kosuke
    Komeda, Yoriaki
    Takenaka, Mamoru
    Sakurai, Toshiharu
    Watanabe, Tomohiro
    Nishida, Naoshi
    Kudo, Masatoshi
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 589 - 597
  • [4] Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Minami, Tomohiro
    Kono, Masashi
    Chishina, Hirokazu
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    [J]. LIVER CANCER, 2015, 4 (04) : 253 - 262
  • [5] Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
    Bolondi, Luigi
    Burroughs, Andrew
    Dufour, Jean-Francois
    Galle, Peter R.
    Mazzaferro, Vincenzo
    Piscaglia, Fabio
    Raoul, Jean Luc
    Sangro, Bruno
    [J]. SEMINARS IN LIVER DISEASE, 2012, 32 (04) : 348 - 359
  • [6] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
    Bruix, Jordi
    Qin, Shukui
    Merle, Philippe
    Granito, Alessandro
    Huang, Yi-Hsiang
    Bodoky, Gyrogy
    Pracht, Marc
    Yokosuka, Osamu
    Rosmorduc, Olivier
    Breder, Valeriy
    Gerolami, Rene
    Masi, Gianluca
    Ross, Paul J.
    Song, Tianqiang
    Bronowicki, Jean-Pierre
    Ollivier-Hourmand, Isabelle
    Kudo, Masatoshi
    Cheng, Ann-Lii
    Llovet, Josep M.
    Finn, Richard S.
    LeBerre, Marie-Aude
    Baumhauer, Annette
    Meinhardt, Gerold
    Han, Guohong
    [J]. LANCET, 2017, 389 (10064) : 56 - 66
  • [7] Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
    Bruix, Jordi
    Reig, Maria
    Sherman, Morris
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : 835 - 853
  • [8] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [9] Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
    Cheng, Ann Lii
    Amarapurkar, Deepak
    Chao, Yee
    Chen, Pei-Jer
    Geschwind, Jean-Francois
    Goh, Khean L.
    Han, Kwang-Hyub
    Kudo, Masatoshi
    Lee, Han Chu
    Lee, Rheun-Chuan
    Lesmana, Laurentius A.
    Lim, Ho Yeong
    Paik, Seung Woon
    Poon, Ronnie T.
    Tan, Chee-Kiat
    Tanwandee, Tawesak
    Teng, Gaojun
    Park, Joong-Won
    [J]. LIVER INTERNATIONAL, 2014, 34 (02) : 174 - 183
  • [10] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng, Ann-Lii
    Kang, Yoon-Koo
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Luo, Rongcheng
    Feng, Jifeng
    Ye, Shenglong
    Yang, Tsai-Sheng
    Xu, Jianming
    Sun, Yan
    Liang, Houjie
    Liu, Jiwei
    Wang, Jiejun
    Tak, Won Young
    Pan, Hongming
    Burock, Karin
    Zou, Jessie
    Voliotis, Dimitris
    Guan, Zhongzhen
    [J]. LANCET ONCOLOGY, 2009, 10 (01) : 25 - 34
12345